30.2 C
Saturday, May 18, 2024

AstraZeneca reaches 10m dose vaccine shipment milestone in PH 

- Advertisement -

Bio-pharmaceutical company AstraZeneca has delivered over 10 million doses of its COVID-19 vaccine to the Philippines following its recent shipment in October. 

On Oct. 8, 661,100 doses of AstraZeneca vaccine arrived in the country to support our mass vaccination program. 

Over 10 million doses of COVID-19 Vaccine AstraZeneca have been delivered to the Philippines as of Oct. 8.
Over 10 million doses of COVID-19 Vaccine AstraZeneca have been delivered to the Philippines as of Oct. 8.

“The arrival of this latest batch will help ramp up the vaccination rollout among our workers as part of our effort to protect their ranks from the dreaded Delta variant. Having all of our workers vaccinated against COVID-19 will also contribute to the safe reopening of our economy that we are all hoping for in the last quarter of the year,” said Joey Concepcion, Presidential Adviser for Entrepreneurship and Go Negosyo founder.

In partnership with the national government, local government, and the private sector, the company says it is on track to deliver millions more doses between today and early next year through the COVAX facility. 

“Our collaboration with the government and private sector – which we define and practice as ‘bayanihan’ – is essential to our ongoing efforts to vaccinate people as quickly as possible during this pandemic,” said Lotis Ramin, AstraZeneca Philippines country president. 

To date, more than 1.3 billion doses of AstraZeneca’s vaccine have been released for supply to over 170 countries globally, and approximately two-thirds of these doses have been delivered to low- and lower-middle-income countries.

More than 145 million doses of its COVID-19 vaccine have been delivered through the COVAX facility. 

In clinical trials, AstraZeneca’s COVID-19 jabs demonstrated 100 percent efficacy against severe disease and hospitalization after two doses. Real-world evidence shows the vaccine is around 80 to 90 percent effective against severe disease.


Popular Articles